# A Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 Diabetes

> **NCT07270731** · PHASE1 · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 72 (estimated)

## Conditions studied

- Healthy Volunteer
- Type 2 Diabetes

## Interventions

- **DRUG:** NNC9733-0001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07270731
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-25
- **Primary completion:** 2027-08-30
- **Final completion:** 2027-11-12
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07270731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07270731, "A Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07270731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*